跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“Abbisko”
全部
20
临床试验
0
药物
1
机构
1
资讯
18
去年
Pimicotinib Shows Promise in Phase 2 Trial for Chronic Graft-versus-Host Disease
去年
Pimicotinib Shows Positive Phase 3 Results in Tenosynovial Giant Cell Tumors
去年
Abbisko Cayman Initiates Phase II Trial of ABSK043 in Advanced NSCLC
去年
Pimicotinib Shows Positive Phase 3 Results for Tenosynovial Giant Cell Tumor
去年
Abbisko Cayman Initiates Phase II Trial of ABSK061 and ABSK043 for Advanced Solid Tumors
3个月前
Abbisko Teams Up With Eli Lilly in Up to $1.9 Billion Oncology Drug Discovery Collaboration
去年
Abbisko Therapeutics' Pimicotinib Achieves Primary Endpoints in Phase III Study for GIST
去年
Abbisko's FGFR4 Inhibitor Irpagratinib Receives China's Breakthrough Therapy Designation for Hepatocellular Carcinoma
去年
Abbisko's Pimicotinib Shows Promise in Phase 3 Trial for Tenosynovial Giant Cell Tumor
去年
Abbisko's Irpagratinib-Atezolizumab Combination Shows Promising Results for Advanced Liver Cancer
第 1 页,共 2 页
上一页
下一页